Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 173 entries
Sorted by: Best Match Show Resources per page
Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia.

Frontiers in oncology

Chapuis N, Poulain L, Birsen R, Tamburini J, Bouscary D.
PMID: 31192118
Front Oncol. 2019 May 22;9:405. doi: 10.3389/fonc.2019.00405. eCollection 2019.

Metabolic reprogramming is a common cancer cell phenotype as it sustains growth and proliferation. Targeting metabolic activities offers a wide range of therapeutic possibilities which are applicable to acute myeloid leukemia (AML). Indeed, in addition to the IDH1/2-mutated AML...

Cite
Chapuis N, Poulain L, Birsen R, et al. Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia. Front Oncol. 2019;9:405doi: 10.3389/fonc.2019.00405.
Chapuis, N., Poulain, L., Birsen, R., Tamburini, J., & Bouscary, D. (2019). Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia. Frontiers in oncology, 9405. https://doi.org/10.3389/fonc.2019.00405
Chapuis, Nicolas, et al. "Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia." Frontiers in oncology vol. 9 (2019): 405. doi: https://doi.org/10.3389/fonc.2019.00405
Chapuis N, Poulain L, Birsen R, Tamburini J, Bouscary D. Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia. Front Oncol. 2019 May 22;9:405. doi: 10.3389/fonc.2019.00405. eCollection 2019. PMID: 31192118; PMCID: PMC6540604.
Copy Download .nbib Format: NLM
Erratum to: Predictors of Perianal Fistula Relapse in Crohn's Disease.

Inflammatory bowel diseases

Malian A, Rivière P, Bouchard D, Pigot F, Eléouet-Kaplan M, Favreau-Weltzer C, Poullenot F, Laharie D.
PMID: 33277906
Inflamm Bowel Dis. 2021 Jul 27;27(8):1365. doi: 10.1093/ibd/izaa272.

No abstract available.

Cite
Malian A, Rivière P, Bouchard D, et al. Erratum to: Predictors of Perianal Fistula Relapse in Crohn's Disease. Inflamm Bowel Dis. 2021;27(8):1365doi: 10.1093/ibd/izaa272.
Malian, A., Rivière, P., Bouchard, D., Pigot, F., Eléouet-Kaplan, M., Favreau-Weltzer, C., Poullenot, F., & Laharie, D. (2021). Erratum to: Predictors of Perianal Fistula Relapse in Crohn's Disease. Inflammatory bowel diseases, 27(8), 1365. https://doi.org/10.1093/ibd/izaa272
Malian, Audrey, et al. "Erratum to: Predictors of Perianal Fistula Relapse in Crohn's Disease." Inflammatory bowel diseases vol. 27,8 (2021): 1365. doi: https://doi.org/10.1093/ibd/izaa272
Malian A, Rivière P, Bouchard D, Pigot F, Eléouet-Kaplan M, Favreau-Weltzer C, Poullenot F, Laharie D. Erratum to: Predictors of Perianal Fistula Relapse in Crohn's Disease. Inflamm Bowel Dis. 2021 Jul 27;27(8):1365. doi: 10.1093/ibd/izaa272. PMID: 33277906.
Copy Download .nbib Format: NLM
Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia.

Oncogenesis

Meunier G, Birsen R, Cazelles C, Belhadj M, Cantero-Aguilar L, Kosmider O, Fontenay M, Azar N, Mayeux P, Chapuis N, Tamburini J, Bouscary D.
PMID: 33093450
Oncogenesis. 2020 Oct 22;9(10):94. doi: 10.1038/s41389-020-00278-8.

Acute myeloid leukemia (AML) is an aggressive disease with a poor prognosis. Vacuolar protein sorting 34 (VPS34) is a member of the phosphatidylinositol-3-kinase lipid kinase family that controls the canonical autophagy pathway and vesicular trafficking. Using a recently developed...

Cite
Meunier G, Birsen R, Cazelles C, et al. Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia. Oncogenesis. 2020;9(10):94doi: 10.1038/s41389-020-00278-8.
Meunier, G., Birsen, R., Cazelles, C., Belhadj, M., Cantero-Aguilar, L., Kosmider, O., Fontenay, M., Azar, N., Mayeux, P., Chapuis, N., Tamburini, J., & Bouscary, D. (2020). Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia. Oncogenesis, 9(10), 94. https://doi.org/10.1038/s41389-020-00278-8
Meunier, Godelieve, et al. "Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia." Oncogenesis vol. 9,10 (2020): 94. doi: https://doi.org/10.1038/s41389-020-00278-8
Meunier G, Birsen R, Cazelles C, Belhadj M, Cantero-Aguilar L, Kosmider O, Fontenay M, Azar N, Mayeux P, Chapuis N, Tamburini J, Bouscary D. Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia. Oncogenesis. 2020 Oct 22;9(10):94. doi: 10.1038/s41389-020-00278-8. PMID: 33093450; PMCID: PMC7581748.
Copy Download .nbib Format: NLM
Head and neck skin expansion: assessment of efficiency for the treatment of lesions in the lower half of the face.

Annals of burns and fire disasters

Sabban R, Serror K, Levy J, Chaouat M, Mimoun M, Boccara D.
PMID: 32523494
Ann Burns Fire Disasters. 2020 Mar 31;33(1):38-46.

The treatment of sequelae for burns or other loss of perioral tissues is complex due to the site where they occur, its functional importance, and social and esthetic aspects. Functional consequences of burns to this area are cutaneous retraction...

Cite
Sabban R, Serror K, Levy J, et al. Head and neck skin expansion: assessment of efficiency for the treatment of lesions in the lower half of the face. Ann Burns Fire Disasters. 2020;33(1):38-46
Sabban, R., Serror, K., Levy, J., Chaouat, M., Mimoun, M., & Boccara, D. (2020). Head and neck skin expansion: assessment of efficiency for the treatment of lesions in the lower half of the face. Annals of burns and fire disasters, 33(1), 38-46.
Sabban, R, et al. "Head and neck skin expansion: assessment of efficiency for the treatment of lesions in the lower half of the face." Annals of burns and fire disasters vol. 33,1 (2020): 38-46.
Sabban R, Serror K, Levy J, Chaouat M, Mimoun M, Boccara D. Head and neck skin expansion: assessment of efficiency for the treatment of lesions in the lower half of the face. Ann Burns Fire Disasters. 2020 Mar 31;33(1):38-46. PMID: 32523494; PMCID: PMC7263714.
Copy Download .nbib Format: NLM
Burns Caused by Exploding Standing Electric Scooters (E-Scooters): A New Phenomenon.

Journal of burn care & research : official publication of the American Burn Association

Ragonez D, Mimoun M, Chaouat M, Levy S, Vairinho A, Boccara D, Serror K.
PMID: 33156906
J Burn Care Res. 2021 Mar 04;42(2):348-349. doi: 10.1093/jbcr/iraa201.

No abstract available.

Cite
Ragonez D, Mimoun M, Chaouat M, et al. Burns Caused by Exploding Standing Electric Scooters (E-Scooters): A New Phenomenon. J Burn Care Res. 2021;42(2):348-349doi: 10.1093/jbcr/iraa201.
Ragonez, D., Mimoun, M., Chaouat, M., Levy, S., Vairinho, A., Boccara, D., & Serror, K. (2021). Burns Caused by Exploding Standing Electric Scooters (E-Scooters): A New Phenomenon. Journal of burn care & research : official publication of the American Burn Association, 42(2), 348-349. https://doi.org/10.1093/jbcr/iraa201
Ragonez, David, et al. "Burns Caused by Exploding Standing Electric Scooters (E-Scooters): A New Phenomenon." Journal of burn care & research : official publication of the American Burn Association vol. 42,2 (2021): 348-349. doi: https://doi.org/10.1093/jbcr/iraa201
Ragonez D, Mimoun M, Chaouat M, Levy S, Vairinho A, Boccara D, Serror K. Burns Caused by Exploding Standing Electric Scooters (E-Scooters): A New Phenomenon. J Burn Care Res. 2021 Mar 04;42(2):348-349. doi: 10.1093/jbcr/iraa201. PMID: 33156906.
Copy Download .nbib Format: NLM
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 1: .

EFSA journal. European Food Safety Authority

, Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Herman L, Hilbert F, Lindqvist R, Nauta M, Ru G, Simmons M, Skandamis P, Suffredini E, Andersson DI, Bampidis V, Bengtsson-Palme J, Bouchard D, Ferran A, Kouba M, López Puente S, López-Alonso M, Nielsen SS, Pechová A, Petkova M, Girault S, Broglia A, Guerra B, Innocenti ML, Liébana E, López-Gálvez G, Manini P, Stella P, Peixe L.
PMID: 34729081
EFSA J. 2021 Oct 26;19(10):e06852. doi: 10.2903/j.efsa.2021.6852. eCollection 2021 Oct.

The European Commission requested EFSA to assess, in collaboration with EMA, the specific concentrations of antimicrobials resulting from cross-contamination in non-target feed for food-producing animals below which there would not be an effect on the emergence of, and/or selection...

Cite
, Koutsoumanis K, Allende A, et al. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 1: . EFSA J. 2021;19(10):e06852doi: 10.2903/j.efsa.2021.6852.
, Koutsoumanis, K., Allende, A., Alvarez-Ordóñez, A., Bolton, D., Bover-Cid, S., Chemaly, M., Davies, R., De Cesare, A., Herman, L., Hilbert, F., Lindqvist, R., Nauta, M., Ru, G., Simmons, M., Skandamis, P., Suffredini, E., Andersson, D. I., Bampidis, V., Bengtsson-Palme, J., Bouchard, D., Ferran, A., Kouba, M., López Puente, S., López-Alonso, M., Nielsen, S. S., Pechová, A., Petkova, M., Girault, S., Broglia, A., Guerra, B., Innocenti, M. L., Liébana, E., López-Gálvez, G., Manini, P., Stella, P., & Peixe, L. (2021). Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 1: . EFSA journal. European Food Safety Authority, 19(10), e06852. https://doi.org/10.2903/j.efsa.2021.6852
, et al. "Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 1: ." EFSA journal. European Food Safety Authority vol. 19,10 (2021): e06852. doi: https://doi.org/10.2903/j.efsa.2021.6852
, Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Herman L, Hilbert F, Lindqvist R, Nauta M, Ru G, Simmons M, Skandamis P, Suffredini E, Andersson DI, Bampidis V, Bengtsson-Palme J, Bouchard D, Ferran A, Kouba M, López Puente S, López-Alonso M, Nielsen SS, Pechová A, Petkova M, Girault S, Broglia A, Guerra B, Innocenti ML, Liébana E, López-Gálvez G, Manini P, Stella P, Peixe L. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 1: . EFSA J. 2021 Oct 26;19(10):e06852. doi: 10.2903/j.efsa.2021.6852. eCollection 2021 Oct. PMID: 34729081; PMCID: PMC8547316.
Copy Download .nbib Format: NLM
Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 2: .

EFSA journal. European Food Safety Authority

, Allende A, Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Herman L, Hilbert F, Lindqvist R, Nauta M, Ru G, Simmons M, Skandamis P, Suffredini E, Andersson DI, Bampidis V, Bengtsson-Palme J, Bouchard D, Ferran A, Kouba M, López Puente S, López-Alonso M, Nielsen SS, Pechová A, Petkova M, Girault S, Broglia A, Guerra B, Innocenti ML, Liébana E, López-Gálvez G, Manini P, Stella P, Peixe L.
PMID: 34729082
EFSA J. 2021 Oct 26;19(10):e06853. doi: 10.2903/j.efsa.2021.6853. eCollection 2021 Oct.

The specific concentrations of apramycin, paromomycin, neomycin and spectinomycin in non-target feed for food-producing animals, below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health,...

Cite
, Allende A, Koutsoumanis K, et al. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 2: . EFSA J. 2021;19(10):e06853doi: 10.2903/j.efsa.2021.6853.
, Allende, A., Koutsoumanis, K., Allende, A., Alvarez-Ordóñez, A., Bolton, D., Bover-Cid, S., Chemaly, M., Davies, R., De Cesare, A., Herman, L., Hilbert, F., Lindqvist, R., Nauta, M., Ru, G., Simmons, M., Skandamis, P., Suffredini, E., Andersson, D. I., Bampidis, V., Bengtsson-Palme, J., Bouchard, D., Ferran, A., Kouba, M., López Puente, S., López-Alonso, M., Nielsen, S. S., Pechová, A., Petkova, M., Girault, S., Broglia, A., Guerra, B., Innocenti, M. L., Liébana, E., López-Gálvez, G., Manini, P., Stella, P., & Peixe, L. (2021). Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 2: . EFSA journal. European Food Safety Authority, 19(10), e06853. https://doi.org/10.2903/j.efsa.2021.6853
, et al. "Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 2: ." EFSA journal. European Food Safety Authority vol. 19,10 (2021): e06853. doi: https://doi.org/10.2903/j.efsa.2021.6853
, Allende A, Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Herman L, Hilbert F, Lindqvist R, Nauta M, Ru G, Simmons M, Skandamis P, Suffredini E, Andersson DI, Bampidis V, Bengtsson-Palme J, Bouchard D, Ferran A, Kouba M, López Puente S, López-Alonso M, Nielsen SS, Pechová A, Petkova M, Girault S, Broglia A, Guerra B, Innocenti ML, Liébana E, López-Gálvez G, Manini P, Stella P, Peixe L. Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed.
Part 2: . EFSA J. 2021 Oct 26;19(10):e06853. doi: 10.2903/j.efsa.2021.6853. eCollection 2021 Oct. PMID: 34729082; PMCID: PMC8546520.
Copy Download .nbib Format: NLM
Environmental contamination in a high-income country (France) by antibiotics, antibiotic-resistant bacteria, and antibiotic resistance genes: Status and possible causes.

Environment international

Haenni M, Dagot C, Chesneau O, Bibbal D, Labanowski J, Vialette M, Bouchard D, Martin-Laurent F, Calsat L, Nazaret S, Petit F, Pourcher AM, Togola A, Bachelot M, Topp E, Hocquet D.
PMID: 34923370
Environ Int. 2021 Dec 16;159:107047. doi: 10.1016/j.envint.2021.107047. Epub 2021 Dec 16.

Antimicrobial resistance (AMR) is a major global public health concern, shared by a large number of human and animal health actors. Within the framework of a One Health approach, actions should be implemented in the environmental realm, as well...

Cite
Haenni M, Dagot C, Chesneau O, et al. Environmental contamination in a high-income country (France) by antibiotics, antibiotic-resistant bacteria, and antibiotic resistance genes: Status and possible causes. Environ Int. 2021;159:107047doi: 10.1016/j.envint.2021.107047.
Haenni, M., Dagot, C., Chesneau, O., Bibbal, D., Labanowski, J., Vialette, M., Bouchard, D., Martin-Laurent, F., Calsat, L., Nazaret, S., Petit, F., Pourcher, A. M., Togola, A., Bachelot, M., Topp, E., & Hocquet, D. (2021). Environmental contamination in a high-income country (France) by antibiotics, antibiotic-resistant bacteria, and antibiotic resistance genes: Status and possible causes. Environment international, 159107047. https://doi.org/10.1016/j.envint.2021.107047
Haenni, Marisa, et al. "Environmental contamination in a high-income country (France) by antibiotics, antibiotic-resistant bacteria, and antibiotic resistance genes: Status and possible causes." Environment international vol. 159 (2021): 107047. doi: https://doi.org/10.1016/j.envint.2021.107047
Haenni M, Dagot C, Chesneau O, Bibbal D, Labanowski J, Vialette M, Bouchard D, Martin-Laurent F, Calsat L, Nazaret S, Petit F, Pourcher AM, Togola A, Bachelot M, Topp E, Hocquet D. Environmental contamination in a high-income country (France) by antibiotics, antibiotic-resistant bacteria, and antibiotic resistance genes: Status and possible causes. Environ Int. 2021 Dec 16;159:107047. doi: 10.1016/j.envint.2021.107047. Epub 2021 Dec 16. PMID: 34923370.
Copy Download .nbib Format: NLM
Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells.

Molecular metabolism

Trinh A, Khamari R, Fovez Q, Mahon FX, Turcq B, Bouscary D, Maboudou P, Joncquel M, Coiteux V, Germain N, Laine W, Dekiouk S, Jean-Pierre S, Maguer-Satta V, Ghesquiere B, Idziorek T, Quesnel B, Kluza J, Marchetti P.
PMID: 34863941
Mol Metab. 2021 Dec 01;55:101410. doi: 10.1016/j.molmet.2021.101410. Epub 2021 Dec 01.

OBJECTIVE: Long-term treatment with tyrosine kinase inhibitors (TKI) represents an effective cure for chronic myeloid leukemia (CML) patients and discontinuation of TKI therapy is now proposed to patient with deep molecular responses. However, evidence demonstrating that TKI are unable...

Cite
Trinh A, Khamari R, Fovez Q, et al. Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells. Mol Metab. 2021;55:101410doi: 10.1016/j.molmet.2021.101410.
Trinh, A., Khamari, R., Fovez, Q., Mahon, F. X., Turcq, B., Bouscary, D., Maboudou, P., Joncquel, M., Coiteux, V., Germain, N., Laine, W., Dekiouk, S., Jean-Pierre, S., Maguer-Satta, V., Ghesquiere, B., Idziorek, T., Quesnel, B., Kluza, J., & Marchetti, P. (2021). Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells. Molecular metabolism, 55101410. https://doi.org/10.1016/j.molmet.2021.101410
Trinh, Anne, et al. "Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells." Molecular metabolism vol. 55 (2021): 101410. doi: https://doi.org/10.1016/j.molmet.2021.101410
Trinh A, Khamari R, Fovez Q, Mahon FX, Turcq B, Bouscary D, Maboudou P, Joncquel M, Coiteux V, Germain N, Laine W, Dekiouk S, Jean-Pierre S, Maguer-Satta V, Ghesquiere B, Idziorek T, Quesnel B, Kluza J, Marchetti P. Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells. Mol Metab. 2021 Dec 01;55:101410. doi: 10.1016/j.molmet.2021.101410. Epub 2021 Dec 01. PMID: 34863941; PMCID: PMC8732793.
Copy Download .nbib Format: NLM
ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY-APPROVED L-ASPARAGINASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS.

Molecular metabolism

Trinh A, Khamari R, Fovez Q, Mahon FX, Turcq B, Bouscary D, Maboudou P, Joncquel M, Coiteux V, Germain N, Laine W, Dekiouk S, Jean-Pierre S, Maguer-Satta V, Ghesquiere B, Idziorek T, Quesnel B, Kluza J, Marchetti P.
PMID: 34863941
Mol Metab. 2021 Dec 01;101410. doi: 10.1016/j.molmet.2021.101410. Epub 2021 Dec 01.

Long-term treatment with tyrosine kinase inhibitors (TKI) represents an effective treatment for chronic myeloid leukemia (CML) and discontinuation of TKI therapy is now being proposed to patients with deep molecular responses. However, evidence demonstrating that TKI are unable to...

Cite
Trinh A, Khamari R, Fovez Q, et al. ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY-APPROVED L-ASPARAGINASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS. Mol Metab. 2021;101410doi: 10.1016/j.molmet.2021.101410.
Trinh, A., Khamari, R., Fovez, Q., Mahon, F. X., Turcq, B., Bouscary, D., Maboudou, P., Joncquel, M., Coiteux, V., Germain, N., Laine, W., Dekiouk, S., Jean-Pierre, S., Maguer-Satta, V., Ghesquiere, B., Idziorek, T., Quesnel, B., Kluza, J., & Marchetti, P. (2021). ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY-APPROVED L-ASPARAGINASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS. Molecular metabolism, 101410. https://doi.org/10.1016/j.molmet.2021.101410
Trinh, Anne, et al. "ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY-APPROVED L-ASPARAGINASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS." Molecular metabolism vol. (2021): 101410. doi: https://doi.org/10.1016/j.molmet.2021.101410
Trinh A, Khamari R, Fovez Q, Mahon FX, Turcq B, Bouscary D, Maboudou P, Joncquel M, Coiteux V, Germain N, Laine W, Dekiouk S, Jean-Pierre S, Maguer-Satta V, Ghesquiere B, Idziorek T, Quesnel B, Kluza J, Marchetti P. ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY-APPROVED L-ASPARAGINASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS. Mol Metab. 2021 Dec 01;101410. doi: 10.1016/j.molmet.2021.101410. Epub 2021 Dec 01. PMID: 34863941.
Copy Download .nbib Format: NLM
Nature of phase transitions in a probabilistic cellular automaton with two absorbing states.

Physical review. E, Statistical, nonlinear, and soft matter physics

Bagnoli F, Boccara N, Rechtman R.
PMID: 11308921
Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Apr;63(4):046116. doi: 10.1103/PhysRevE.63.046116. Epub 2001 Mar 29.

We present a probabilistic cellular automaton with two absorbing states, which can be considered a natural extension of the Domany-Kinzel model. Despite its simplicity, it shows a very rich phase diagram, with two second-order and one first-order transition lines...

Cite
Bagnoli F, Boccara N, Rechtman R. Nature of phase transitions in a probabilistic cellular automaton with two absorbing states. Phys Rev E Stat Nonlin Soft Matter Phys. 2001;63(4):046116doi: 10.1103/PhysRevE.63.046116.
Bagnoli, F., Boccara, N., & Rechtman, R. (2001). Nature of phase transitions in a probabilistic cellular automaton with two absorbing states. Physical review. E, Statistical, nonlinear, and soft matter physics, 63(4), 046116. https://doi.org/10.1103/PhysRevE.63.046116
Bagnoli, F, et al. "Nature of phase transitions in a probabilistic cellular automaton with two absorbing states." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 63,4 (2001): 046116. doi: https://doi.org/10.1103/PhysRevE.63.046116
Bagnoli F, Boccara N, Rechtman R. Nature of phase transitions in a probabilistic cellular automaton with two absorbing states. Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Apr;63(4):046116. doi: 10.1103/PhysRevE.63.046116. Epub 2001 Mar 29. PMID: 11308921.
Copy Download .nbib Format: NLM
Nanotectonic approach of the texturation of CeO2 based nanomaterials.

Chemical communications (Cambridge, England)

Bouchara A, Soler-Illia GJ, Chane-Ching JY, Sanchez C.
PMID: 12109098
Chem Commun (Camb). 2002 Jun 07;(11):1234-5. doi: 10.1039/b202316b.

Original and homogeneous macrotextures shaped with coral-like, helical or macroporous sieves morphologies are obtained following a nanotectonic approach based on the template-directed assembly by poly-gamma-benzyl-L-glutamate (PBLG) of organically functionalised CeO2 crystalline nanoparticles.

Cite
Bouchara A, Soler-Illia GJ, Chane-Ching JY, et al. Nanotectonic approach of the texturation of CeO2 based nanomaterials. Chem Commun (Camb). 2002;(11):1234-5doi: 10.1039/b202316b.
Bouchara, A., Soler-Illia, G. J., Chane-Ching, J. Y., & Sanchez, C. (2002). Nanotectonic approach of the texturation of CeO2 based nanomaterials. Chemical communications (Cambridge, England), (11), 1234-5. https://doi.org/10.1039/b202316b
Bouchara, Anne, et al. "Nanotectonic approach of the texturation of CeO2 based nanomaterials." Chemical communications (Cambridge, England) vol. ,11 (2002): 1234-5. doi: https://doi.org/10.1039/b202316b
Bouchara A, Soler-Illia GJ, Chane-Ching JY, Sanchez C. Nanotectonic approach of the texturation of CeO2 based nanomaterials. Chem Commun (Camb). 2002 Jun 07;(11):1234-5. doi: 10.1039/b202316b. PMID: 12109098.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 173 entries